NO20040235L - Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider - Google Patents
Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptiderInfo
- Publication number
- NO20040235L NO20040235L NO20040235A NO20040235A NO20040235L NO 20040235 L NO20040235 L NO 20040235L NO 20040235 A NO20040235 A NO 20040235A NO 20040235 A NO20040235 A NO 20040235A NO 20040235 L NO20040235 L NO 20040235L
- Authority
- NO
- Norway
- Prior art keywords
- polypeptides
- factor
- pharmaceutical preparation
- factor vii
- vii polypeptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200101127 | 2001-07-20 | ||
PCT/DK2002/000505 WO2003007983A1 (en) | 2001-07-20 | 2002-07-19 | Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20040235L true NO20040235L (no) | 2004-03-17 |
Family
ID=8160632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20040235A NO20040235L (no) | 2001-07-20 | 2004-01-19 | Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1411973A1 (pt) |
JP (1) | JP2004534855A (pt) |
KR (1) | KR20040015821A (pt) |
CN (1) | CN1304050C (pt) |
AU (1) | AU2002354846B2 (pt) |
BR (1) | BR0211256A (pt) |
CA (1) | CA2452677A1 (pt) |
CZ (1) | CZ200439A3 (pt) |
HU (1) | HUP0400976A3 (pt) |
IL (1) | IL159622A0 (pt) |
MX (1) | MXPA04000415A (pt) |
NO (1) | NO20040235L (pt) |
PL (1) | PL369077A1 (pt) |
RU (1) | RU2298416C2 (pt) |
WO (1) | WO2003007983A1 (pt) |
ZA (1) | ZA200400012B (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100411684C (zh) | 1999-07-14 | 2008-08-20 | 诺沃挪第克健康护理股份公司 | FVIIa或组织因子拮抗剂在调节基因表达和细胞迁移或趋化中的应用 |
ES2381110T3 (es) | 2003-09-09 | 2012-05-23 | Novo Nordisk Health Care Ag | Polipéptidos de factor VII de coagulación |
BRPI0416461A (pt) * | 2003-11-20 | 2007-03-06 | Novo Nordisk Healthcare Ag | método para o tratamento de episódios de sangramento, formulação farmacêutica, e, uso de um polipeptìdeo fxi |
WO2005074974A1 (en) * | 2004-02-05 | 2005-08-18 | Novo Nordisk Health Care Ag | Use of factor viia for treating late complications of trauma |
WO2006128497A1 (en) * | 2005-06-01 | 2006-12-07 | Novo Nordisk A/S | Pharmaceutical formulation of factor xi |
JP5739816B2 (ja) | 2008-12-19 | 2015-06-24 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | Tfpiインヒビターおよび使用法 |
NZ603028A (en) | 2010-03-19 | 2014-11-28 | Baxter Healthcare Sa | Tfpi inhibitors and methods of use |
AU2011313505B2 (en) * | 2010-10-06 | 2015-09-17 | Medimmune Limited | Factor II and fibrinogen for treatment of haemostatic disorders |
KR102263685B1 (ko) | 2012-03-21 | 2021-06-11 | 다케다 야쿠힌 고교 가부시키가이샤 | Tfpi 저해제 및 사용 방법 |
EP3099171A4 (en) * | 2014-01-31 | 2017-08-09 | Dana-Farber Cancer Institute, Inc. | Dihydropteridinone derivatives and uses thereof |
WO2016201370A1 (en) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
CR20180336A (es) | 2015-11-25 | 2018-08-06 | Dana Farber Cancer Inst Inc | Inhibidores de bromodominio bivalentes y usos de los mismos |
US11958911B2 (en) | 2017-02-10 | 2024-04-16 | Shanghai Benemae Pharmaceutical | Anti-coagulation factor XI antibody |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59116213A (ja) * | 1982-12-24 | 1984-07-05 | Unitika Ltd | エアゾ−ル組成物 |
JPH0780783B2 (ja) * | 1985-11-26 | 1995-08-30 | ノボ ノルディスク アクティーゼルスカブ | 出血障害の治療のための第▲VII▼a因子を含有する治療組成物 |
US5580560A (en) * | 1989-11-13 | 1996-12-03 | Novo Nordisk A/S | Modified factor VII/VIIa |
FR2676231A1 (fr) * | 1991-05-07 | 1992-11-13 | Aetsrn | Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation. |
EP2253703A1 (en) * | 2000-09-13 | 2010-11-24 | Novo Nordisk Health Care AG | Human coagulation factor VII variants |
-
2002
- 2002-07-19 JP JP2003513588A patent/JP2004534855A/ja active Pending
- 2002-07-19 CN CNB028185390A patent/CN1304050C/zh not_active Expired - Fee Related
- 2002-07-19 BR BR0211256-6A patent/BR0211256A/pt not_active IP Right Cessation
- 2002-07-19 PL PL02369077A patent/PL369077A1/xx not_active Application Discontinuation
- 2002-07-19 AU AU2002354846A patent/AU2002354846B2/en not_active Ceased
- 2002-07-19 WO PCT/DK2002/000505 patent/WO2003007983A1/en not_active Application Discontinuation
- 2002-07-19 KR KR10-2004-7000911A patent/KR20040015821A/ko not_active Application Discontinuation
- 2002-07-19 CA CA002452677A patent/CA2452677A1/en not_active Abandoned
- 2002-07-19 MX MXPA04000415A patent/MXPA04000415A/es unknown
- 2002-07-19 HU HU0400976A patent/HUP0400976A3/hu unknown
- 2002-07-19 IL IL15962202A patent/IL159622A0/xx unknown
- 2002-07-19 CZ CZ200439A patent/CZ200439A3/cs unknown
- 2002-07-19 RU RU2004105031/15A patent/RU2298416C2/ru not_active IP Right Cessation
- 2002-07-19 EP EP02750844A patent/EP1411973A1/en not_active Withdrawn
-
2004
- 2004-01-05 ZA ZA200400012A patent/ZA200400012B/en unknown
- 2004-01-19 NO NO20040235A patent/NO20040235L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2452677A1 (en) | 2003-01-30 |
AU2002354846B2 (en) | 2007-08-02 |
KR20040015821A (ko) | 2004-02-19 |
PL369077A1 (en) | 2005-04-18 |
HUP0400976A2 (hu) | 2004-08-30 |
WO2003007983A1 (en) | 2003-01-30 |
CN1304050C (zh) | 2007-03-14 |
MXPA04000415A (es) | 2004-11-22 |
RU2298416C2 (ru) | 2007-05-10 |
CN1556710A (zh) | 2004-12-22 |
RU2004105031A (ru) | 2005-04-20 |
ZA200400012B (en) | 2004-08-17 |
JP2004534855A (ja) | 2004-11-18 |
EP1411973A1 (en) | 2004-04-28 |
HUP0400976A3 (en) | 2006-01-30 |
IL159622A0 (en) | 2004-06-01 |
CZ200439A3 (cs) | 2005-03-16 |
BR0211256A (pt) | 2004-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2023030I1 (no) | Apixaban and pharmaceutical acceptable salts thereof | |
NO20033143D0 (no) | Farmasoytisk preparat | |
NO20044192L (no) | 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater | |
NO20033556D0 (no) | Farmasöytiske preparater | |
DK1417175T3 (da) | Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf | |
NO20030418L (no) | Nytt farmasöytisk preparat | |
NO20033785L (no) | Farmasöytisk formulering | |
FI20011478A0 (fi) | Farmaseuttinen koostumus | |
NO20035627D0 (no) | Farmasöytisk formulering | |
NO20040235L (no) | Farmasoytisk preparat som omfatter faktor VII-polypeptider og faktor XI-polypeptider | |
NO20025805L (no) | Farmasöytisk preparat | |
DE60217390D1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
NO20041485L (no) | Farmasoytisk formulering omfattende (R)-bicalutamid | |
NO20035798L (no) | Tablett som inneholder cetirizin og pseudoefedrin | |
NO20040214L (no) | Kombinasjoner som innebefatter epotiloner og farmasoytiske anvendelser derav | |
NO20042380L (no) | Farmasoytisk preparat omfattende faktor VII-polypeptider og faktor V-polypeptider | |
DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
NO20042379L (no) | Farmasoytisk preparat omfattende faktor VII-polypeptider og PAI-1-polypeptider | |
NO20015534D0 (no) | Farmasöytisk blandeapparat | |
DE10107261B4 (de) | Pharmazeutische Zusammensetzung | |
NO20041236L (no) | Farmasoytisk formulering | |
DK200100256U3 (da) | Amlodipinmaleat og farmaceutiske præparater indeholdende dette | |
SE0102069D0 (sv) | Pharmaceutical formulation | |
SE0101325D0 (sv) | Pharmaceutical formulation | |
SE0103565D0 (sv) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |